Randomised controlled trial of etanercept and methotrexate in very early rheumatoid arthritis with sustained remission after etanercept withdrawal.

Trial Profile

Randomised controlled trial of etanercept and methotrexate in very early rheumatoid arthritis with sustained remission after etanercept withdrawal.

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Jan 2011

At a glance

  • Drugs Etanercept; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2011 Actual end date (31 Dec 2010) added as reported by ISRCTN: Current Controlled Trials.
    • 17 Jan 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 10 Nov 2010 New source identified and integrated (ISRCTN: Current Controlled Trials.).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top